Beckman Coulter Life Sciences Acquires ValitaCell Ltd.

VION Biosciences Acquires Cellular Technology Limited (CTL)

April 8, 2026

Healthcare Services

VION Biosciences has completed its acquisition of Cellular Technology Limited (CTL), a provider of functional immune monitoring analyzers, software, consumables, and services. The deal strengthens VION’s workflow-oriented immune medicine capabilities by adding CTL’s ELISPOT/FluoroSpot platforms, regulatory-grade software, and an established global installed base.

Selvita S.A. Acquires PozLab

May 7, 2024

Pharmaceuticals

Selvita S.A. has completed the acquisition of 100% of the shares in PozLab, a Poznan-based CDMO providing drug product development, analytical and microbiological testing, and small pilot plant manufacturing under GMP. The deal expands Selvita's service offering beyond preclinical research into small-molecule drug manufacturing for early-stage clinical trials and strengthens its position in the pharmaceutical research value chain.

Calibre Scientific Acquires TechniVal Group Limited

January 4, 2023

Medical Devices

Calibre Scientific has acquired TechniVal Group Limited, a Scotland-based provider and distributor of laboratory equipment and services for life science, R&D, pharmaceutical and biotechnology customers across the United Kingdom. The acquisition gives Calibre Scientific a dedicated services capability—installation, calibration, validation, maintenance and repair of temperature-controlled lab equipment—broadening its product and services offering in the British Isles.

Bio-Techne Acquires Namocell

June 22, 2022

Medical Devices

Bio-Techne Corporation has agreed to acquire Namocell, Inc., a Mountain View–based provider of single-cell sorting and dispensing platforms, with the deal expected to close in Bio-Techne's fiscal 2023 Q1. Namocell's Pala and Hana systems (installed base approaching 200 placements, ~60 sold in 2021) will complement Bio-Techne's Cell and Gene Therapy franchise and create commercial synergies across its analytical instruments sales force.

Discovery Life Sciences Acquires QualTek Molecular Laboratories

May 5, 2019

Healthcare Services

Discovery Life Sciences (based in Huntsville, Alabama) has acquired QualTek Molecular Laboratories, a provider of CAP/CLIA-accredited and GLP-capable immunohistochemistry (IHC) laboratories in California and Pennsylvania. The acquisition expands Discovery's histopathology and IHC assay development capabilities and integrates QualTek's services with Discovery's biospecimen, sequencing, flow cytometry and multiomic annotation offerings to accelerate biomarker validation and drug/diagnostic development.

Lonza AG Acquires PharmaCell BV

June 1, 2017

Biotechnology

Lonza AG has completed the acquisition of PharmaCell BV, a leading European contract manufacturer of cell and gene therapies with facilities in Maastricht and Sittard-Geleen. The deal expands Lonza's autologous cell-therapy manufacturing capabilities in Europe and integrates PharmaCell's GMP production capacity and experienced team into Lonza's global CDMO network.